These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21336459)

  • 1. Toll-like receptors, their ligands, and atherosclerosis.
    Hodgkinson CP; Ye S
    ScientificWorldJournal; 2011 Feb; 11():437-53. PubMed ID: 21336459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors and atherosclerosis: key contributors in disease and health?
    Mullick AE; Tobias PS; Curtiss LK
    Immunol Res; 2006; 34(3):193-209. PubMed ID: 16891671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of inflammatory cells and toll-like receptors in atherosclerosis.
    Seneviratne AN; Monaco C
    Curr Vasc Pharmacol; 2015; 13(2):146-60. PubMed ID: 24188491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the innate immune system in atherosclerotic disease.
    Oude Nijhuis MM; van Keulen JK; Pasterkamp G; Quax PH; de Kleijn DP
    Curr Pharm Des; 2007; 13(10):983-94. PubMed ID: 17430162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis.
    Tobias P; Curtiss LK
    J Lipid Res; 2005 Mar; 46(3):404-11. PubMed ID: 15654120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs.
    Gibson FC; Genco CA
    Curr Pharm Des; 2007; 13(36):3665-75. PubMed ID: 18220804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immune signals in atherosclerosis.
    Lundberg AM; Hansson GK
    Clin Immunol; 2010 Jan; 134(1):5-24. PubMed ID: 19740706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential Roles of Toll-Like Receptors in Atherosclerosis.
    Lin J; Kakkar V; Lu X
    Curr Med Chem; 2016; 23(5):431-54. PubMed ID: 26639096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors and macrophage activation in atherosclerosis.
    Seneviratne AN; Sivagurunathan B; Monaco C
    Clin Chim Acta; 2012 Jan; 413(1-2):3-14. PubMed ID: 21884686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis.
    Hovland A; Jonasson L; Garred P; Yndestad A; Aukrust P; Lappegård KT; Espevik T; Mollnes TE
    Atherosclerosis; 2015 Aug; 241(2):480-94. PubMed ID: 26086357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies.
    Cole JE; Kassiteridi C; Monaco C
    Trends Pharmacol Sci; 2013 Nov; 34(11):629-36. PubMed ID: 24139612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and functions of toll-like receptors in atherosclerosis.
    Cole JE; Georgiou E; Monaco C
    Mediators Inflamm; 2010; 2010():393946. PubMed ID: 20652007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.
    Cole JE; Mitra AT; Monaco C
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1619-35. PubMed ID: 21090937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The roles of Toll-like receptors in atherosclerosis.
    Erridge C
    J Innate Immun; 2009; 1(4):340-9. PubMed ID: 20375591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research Progress of Mechanisms and Drug Therapy For Atherosclerosis on Toll-Like Receptor Pathway.
    Yin QY; Zhao B; Qiu YY; Fei YX; Hu YH; Li YM
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):379-388. PubMed ID: 31730559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tolls and dangers of atherosclerotic disease.
    Monaco C
    Curr Pharm Biotechnol; 2012 Jan; 13(1):77-87. PubMed ID: 21470159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors in atherosclerosis.
    Falck-Hansen M; Kassiteridi C; Monaco C
    Int J Mol Sci; 2013 Jul; 14(7):14008-23. PubMed ID: 23880853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.
    Curtiss LK; Tobias PS
    Curr Drug Targets; 2007 Dec; 8(12):1230-8. PubMed ID: 18220700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate immunity, Toll-like receptors, and atherosclerosis: mouse models and methods.
    Sorrentino R; Arditi M
    Methods Mol Biol; 2009; 517():381-99. PubMed ID: 19378021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple roles of Toll-like receptor signaling in atherosclerosis.
    Björkbacka H
    Curr Opin Lipidol; 2006 Oct; 17(5):527-33. PubMed ID: 16960501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.